Q-Sphera
Peptide and protein therapeutics often have to be formulated for subcutaneous or intramuscular injection with sustained release. A compelling commercial proposition is often difficult to achieve with traditional microsphere formulation and manufacturing technologies where yields can be low, due to the requirement for lengthy post-processing, and drug wastage via low entrapment efficiency can be significant.
The Q-Sphera formulation and production platform was developed in response to the unmet requirement for consistent, reproducible and highly efficient production of bioresorbable microspheres for the sustained release of therapeutic products.
Q-Sphera offers the following manufacturing benefits:
